We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

39 hedge funds and large institutions have $166M invested in Mirum Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

71.72% more ownership

Funds ownership: 0% → 71.72% (+72%)

Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
0.86%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
NEA Management Company
Maryland
+$51.4M
2
FM
Frazier Management
Washington
+$43.8M
3
DM
Deerfield Management
New York
+$42.3M
4
NHAS
Novo Holdings A/S
Denmark
+$30M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$14M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$42.1M +$51.4M +4,187,801 New
FM
2
Frazier Management
Washington
$35.9M +$43.8M +3,566,912 New
DM
3
Deerfield Management
New York
$34.7M +$42.3M +3,448,912 New
NHAS
4
Novo Holdings A/S
Denmark
$24.6M +$30M +2,445,147 New
AllianceBernstein
5
AllianceBernstein
Tennessee
$11.5M +$14M +1,144,813 New
RSCM
6
Rock Springs Capital Management
Maryland
$7.95M +$9.69M +790,048 New
BBA
7
Baker Bros. Advisors
New York
$3.35M +$4.09M +333,333 New
Millennium Management
8
Millennium Management
New York
$1.26M +$1.54M +125,424 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$823K +$1M +81,856 New
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$756K +$922K +75,177 New
DIM
11
DC Investments Management
Virginia
$457K +$557K +45,420 New
Northern Trust
12
Northern Trust
Illinois
$370K +$452K +36,813 New
BlackRock
13
BlackRock
New York
$352K +$430K +35,055 New
LCM
14
Landscape Capital Management
New Jersey
$313K +$382K +31,146 New
Federated Hermes
15
Federated Hermes
Pennsylvania
$294K +$359K +29,232 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$211K +$258K +21,058 New
HSBC Holdings
17
HSBC Holdings
United Kingdom
$209K +$255K +20,792 New
State Street
18
State Street
Massachusetts
$197K +$241K +19,616 New
Goldman Sachs
19
Goldman Sachs
New York
$111K +$136K +11,066 New
NAM
20
Nexpoint Asset Management
Texas
$101K +$123K +10,000 New
New York State Common Retirement Fund
21
New York State Common Retirement Fund
New York
$59K +$72.5K +5,912 New
Bank of America
22
Bank of America
North Carolina
$51K +$62.6K +5,101 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$42K +$51.4K +4,191 New
UBS Group
24
UBS Group
Switzerland
$36K +$44K +3,588 New
TAM
25
Tiverton Asset Management
Delaware
$20K +$24.6K +2,006 New
1
2

MIRM Hedge Fund Activity: Q3 2019 in Review

39 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q3 2019, worth a combined $166M.

Buyers outnumbered sellers: 39 funds opened new MIRM positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $51.4M.

  • 39 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $166M of Mirum Pharmaceuticals stock for Q3 2019.
  • 39 funds opened new Mirum Pharmaceuticals positions in Q3 2019 and 0 closed out, a net change of +39 holders.
  • The largest Mirum Pharmaceuticals buyer in Q3 2019 was NEA Management Company, an estimated $51.4M added.

Based on aggregated 13F filings for Q3 2019.